Atlas Trials

Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma

Clinical trial NCT00887107 · COMPLETED

Trial details

NCT number
NCT00887107
Sponsor
Leiden University Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Cancer
Start date
2007-10-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.